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Inarecentstudywefoundnodiﬀerenceintheconcentrationsofluminallactateintherectumbetweennonsurvivorsandsurvivors
in early septic shock (<24h). This study was initiated to investigate if there are any changes in the concentrations of luminal lactate
in the rectum during the ﬁrst 3 days of septic shock and possible diﬀerences between nonsurvivors and survivors. Methods.W e
studied 22 patients with septic shock in this observational study. Six to 24h after the onset of septic shock the concentration of
lactate in the rectal lumen was estimated by 4h equilibrium dialysis (day 1). The rectal dialysis was repeated on day 2 and day 3.
Results.Theconcentrationoflactateintherectallumendidnotchangeoverthe3daysinneithernonsurvivorsnorsurvivors.Rectal
luminal and arterial lactate concentrations were not diﬀerent. Conclusion. There was no change in the concentration of lactate in
the rectal lumen over time in patients with septic shock. Also, there was no diﬀerence between nonsurvivors and survivors.
1.Introduction
Resuscitation of patients with septic shock is most often
guided by only global parameters such as mean arterial
pressure (MAP), central venous pressure (CVP), central
venous oxygen saturation (ScvO2), and arterial lactate [1, 2].
However, patients who appears initially to be adequately
resuscitatedasjudgedbyglobalparametersmaylaterdevelop
multiple organ failure with fatal outcome [3]. Inability of
splanchnic blood ﬂow to meet metabolic demands has been
proposedtobeonefactorinthedevelopmentandpersistence
of multiple organ failure in such patients [3, 4]. Therefore,
diﬀerent techniques have been used to assess splanchnic
blood ﬂow and metabolism [5–8].
Equilibrium dialysis is a simple, minimally invasive
method for the estimation of the concentration of lactate
luminally in the rectum and the method was ﬁrst used to
show diﬀerences in electrolyte transport and production
of inﬂammatory markers in patients with inﬂammatory
bowel disease [9–11]. Using this method in patients with
severe sepsis and septic shock persisting for more than 24h
we have previously shown that luminal concentrations of
lactate in the rectum correlate with large bowel permeability
[12] and disease severity and outcome [13] indicating
pathophysiological relevance. However, in a larger study of
patients with septic shock for less than 24h we observed
low luminal rectal concentrations and no relation between
concentrations of lactate in the rectal lumen and mortality
[14]. Taken together, we have found higher concentrations
of lactate in the rectal lumen in patients with septic shock
for more than 24h than in those patients with septic shock
for less than 24h. These observations suggested that the
rectal lactate concentration could change over time in some
patients and potentially be a marker of outcome.
Therefore, the aim of the present study was to perform
daily rectal equilibrium dialysis for the ﬁrst three days in
patients with septic shock to investigate if the concentration
of lactate in the rectal lumen changed during this period of
time.
2.MaterialsandMethods
The 22 patients were enrolled at the general intensive care
units of Rigshospitalet and Herlev Hospital, University of
Copenhagen, Denmark and the population included both
surgical and medical patients. The regional ethics committee2 Critical Care Research and Practice
approved the study protocol and informed written consent
was obtained from the patient or the next of kin. The
investigation was registered at http://www.clinicaltrials.gov/
(no. NCT00197938).
2.1. Design. This was a prospective, observational, pilot
study with daily consecutive measurements of luminal rectal
lactate concentrations in patients on the ﬁrst 3 days of septic
shock.
Patients were enrolled consecutively when meeting the
following inclusion criteria: (a) septic shock according to
consensus criteria [15] and (b) infusion of vasopressors
for 6–24h. By not including patients in the ﬁrst 6h of
vasopressor treatment the aim was to exclude patients
needing only a short (<6h) period of vasopressor support
during initial resuscitation. All patients were resuscitated
according to the principles of the Surviving Sepsis Campaign
Guidelines and early goal-directed therapy. Thus, the ﬁrst
rectal equilibrium dialysis was performed 6–24h after onset
of shock (day 1) and repeated 24h (day 2) and 48h (day 3)
after the initial dialysis.
Exclusion criteria were age less than 18 years, vasopressor
treatment for more than 24h, rectal bleeding or pathology,
cardiac arrest during the current episode of sepsis, previous
episode of septic shock within current ICU admission or
limitations or impending withdrawal of active therapy of the
patient. Patients were treated according to local guidelines
and clinicians were unaware of the results of the rectal
dialysis.
2.2. Data Registration. The following data were registered in
all patients: arterial lactate, mean arterial blood pressure
(MAP), central venous oxygen saturation (ScvO2), nora-
drenaline dose, and intra-abdominal pressure (IAP). To
calculate the group medians of parameters other than
concentrations of rectal lactate the mean of the registra-
tions done before and after the 4h of rectal dialysis in
individual patients were used. Simpliﬁed acute physiology
scores (SAPS) II were calculated based on values of the
ﬁrst 24h after ICU admission and sequential organ failure
assessment (SOFA) scores were calculated at inclusion and
daily thereafter until either death or discharge from the ICU.
Thirty-day mortality was obtained from hospital registries.
2.3.RectalEquilibriumDialysis. Measurementofrectallumi-
nal lactate was done as previously described [16, 17]. In
brief, a 12cm long bag of dialysis tubing (semipermeable
cellulose, molecular weight cut-oﬀ 12kDa, Sigma, St. Louis,
MO, USA) was ﬁlled with 4mL of 6% dextran 70 in saline
(Macrodex, MEDA Group, Solna, Sweden) and closed over
5cm of Tygon tube (Cole-Parmer Instruments Company,
VernonHills,IL,USA)withathree-waystopcockatthedistal
end to allow sampling. Once ﬁlled, the bag is ﬁrm and can be
easily inserted into the rectal lumen after digital exploration.
Part of the Tygon tube and the three-way stopcock will then
protrude from the anus. The dialysate was sampled after
4h of dialysis, since 90–95% equilibrium with the lactate
concentration in the surrounding medium is obtained at this
time point [17]. Dialysates were analysed immediately at the
study sites using standard blood gas autoanalysers (ABL 725,
Radiometer, Copenhagen, Denmark), which were calibrated
according to the manufacturer’sinstructions. This analyseris
stereospeciﬁc and measures only concentrations of L-lactate.
2.4. Statistics. Continuous variables are presented as medi-
ans (25th–75th percentiles) unless stated otherwise. The
Mann-Whitney test or Fisher’s exact test were performed
where appropriate. The Friedman test (repeated measures)
was used when analysing three paired groups (e.g., changes
in concentrations of luminal rectal lactate over 3 days) and
Wilcoxon’s signed rank test was used when analysing two
paired groups of observations (e.g., changes in concentra-
tions of luminal rectal lactate over 2 days in those patients
with only 2 dialysis periods). All analyses were done using
GraphPad Prism v. 4.00 (GraphPad Software, San Diego,
CA, USA). Values of P<0.05 (two-tailed) were considered
signiﬁcant.
3. Results
The overall 30-day mortality of the study population was
23% (5 nonsurvivors and 17 survivors). The characteristics
of the 22 patients are shown in Table 1.A l lp a t i e n t s
underwent rectal equilibrium dialysis in 2 consecutive days,
but only 15 patients underwent rectal equilibrium dialysis
in all 3 days (3 patients were discharged or transferred to
another ICU, 1 patient died, and 3 patients had profuse
diarrhoea on the 3rd day, so that the dialysis bag slipped out
of the rectum).
3.1. Nonsurvivors and Survivors. There were no diﬀerences
in the concentrations of lactate in the rectal lumen between
nonsurvivors and survivors on any day. On day 1 the
concentration of rectal lactate was 2.4 (1.3–7.5) mmol/L in
nonsurvivors and 2.1 (1.2–4.4) mmol/L in survivors (P =
0.58)seeTable 2.Onday2therectalconcentrationsoflactate
were 3.2 (1.7–4.2) mmol/L and 2.1 (1.1–3.4) mmol/L (P =
0.39) and on day 3 the concentrations were 2.9 (1.5–3.0)
mmol/L and 2.3 (0.9–3.0) mmol/L (P = 0.61), respectively,
(Table 2).
Neither were there any changes in the actual concentra-
tions of lactate in the rectal lumen over the 3 days in neither
nonsurvivors nor survivors; see Figure 1.
Similarly, there were no diﬀerence in arterial values of
lactate between the groups of nonsurvivors or survivors or
within the groups over the days; see Table 2 and Figure 1.
3.2. Changes in Luminal Rectal Lactate over Time. Data were
stratiﬁed according to patients with an increase or a de-
crease/no change in the concentration of lactate in the rectal
lumen from day 1 to day 2 and/or from day 2 to day 3; see
Table 3. Eleven patients had an increase in the concentration
of luminal rectal lactate from day 1 to day 2 with a median
increase of 0.7 (0.1–1.7) mmol/L and 7 patients had an
increase from day 2 to day 3 (1.0 (0.1–1.2) mmol/L). Eleven
patients had a decrease in the concentration of rectal lactateCritical Care Research and Practice 3
Table 1: Characteristics of 22 septic shock patients. Medians (25th–75th percentiles) or numbers (percentage).
Nonsurvivors Survivors P
(n = 5) (n = 17)
Age (years) 68 (51–75) 65 (49–68) 0.43a
Male/female 3/2 12/5 1.00b
Focus of infection
Pulmonary 1 (20%) 7 (41%) 0.61b
Abdominal 1 (20%) 3 (18%) 1.00b
Other or unknown 3 (60%) 3 (18%) 0.10b
Infectious agent
Gram-negative 1 (20%) 2 (12%) 1.00b
Gram-positive 3 (60%) 10 (59%) 1.00b
Both 0 (0%) 1 (7%) 1.00b
Fungi, virus or unknown 1 (20%) 3 (18%) 1.00b
SAPS II 64 (56–75) 48 (39–70) 0.15a
SOFA score at inclusion 12 (9–16) 12 (9–14) 0.78a
Shock duration at 11 (8–17) 12 (9–18) 0.61a
inclusion (hours)
aMann-Whitney test
bFisher’s exact test.
from day 1 to day 2 (−1.0 (−0.3–−4.8) mmol/L) and 8
patients a decrease from day 2 to day 3 (−0.5 (−0.2–−1.7)
mmol/L). There were no diﬀerence in SAPS II, SOFA score at
inclusion or day 5 between the groups with an increase or a
decrease/no change in rectal lactate either from day 1 to day
2o rf r o md a y2t od a y3 .
3.3. Rectal versus Arterial Concentration of Lactate. The lu-
minal rectal and arterial concentrations of lactate did not
diﬀer signiﬁcantly on any day in any group, see Figure 2.
The rectal-arterial gradient (delta-lactate) was not diﬀer-
ent in nonsurvivors on any day and did not change over the
days in either group; see Table 2. There was no correlation
between MAP, noradrenaline dose, intraabdominal pressure
or ScvO2, and rectal lactate concentrations in any group at
any time.
Ninety-day mortality was 41% (9 nonsurvivors and 13
survivors). Results were unchanged when data were analysed
according to 90-day mortality (data not shown).
4. Discussion
There were four main ﬁndings of this study. Firstly, the
concentrations of lactate in the rectal lumen did not change
over the ﬁrst 3 days in patients with septic shock. Secondly,
there was no diﬀerence in the rectal lactate concentrations
between nonsurvivors and survivors. Thirdly, there were no
diﬀerences in SAPS II and SOFA scores at inclusion or day
5 in those patients with increasing concentrations of lactate
in the rectal lumen compared with those patients with a
decrease/no change and fourthly, there was no signiﬁcant
diﬀerence between luminal rectal and arterial concentrations
of lactate.
These ﬁndings raise some important questions. Why
this discrepancy of the observations of these later studies
and the previous study regarding an association between
concentrations of lactate in the rectal lumen and outcome?
Mortality is a “hard” outcome parameter often requiring
larger populations to establish a signiﬁcant diﬀerence, so it is
perhapsnotsurprisingthatwedidnotobserveanydiﬀerence
between nonsurvivors and survivors in the present small
population. However, in the study of early septic shock we
investigated 130 patients [14] and signiﬁcant diﬀerences in
mortalityhavebeenseenbeforeinpatientpopulationsofthis
smaller size, both by ourselves and others [13, 18].
In the previous cohort [13], in which the mortality was
48% (11 of 23 patients), we observed signiﬁcantly higher
concentrations of lactate in the rectal lumen in nonsurvivors
c o m p a r e dt os u r v i v o r so fs e v e r es e p s i so rs e p t i cs h o c k .I n
that study the lactate concentrations in the rectal lumen were
also higher than arterial concentrations and the diﬀerence
were more pronounced (5.0 (0.9–11.8) versus 2.2 (0.4–4.9)
mmol/L; P<0.0001) than the diﬀerence in the arterial
concentrations (3.8 (1.7–7.0) versus 1.6 (0.5–3.6) mmol/L;
P<0.01) between nonsurvivors and survivors. These
ﬁndings suggested that the concentration of lactate in the
rectal lumen could be an important marker of regional
metabolic dysfunction of the gut and distinctly diﬀerent
than arterial concentrations of lactate. Therefore that study
was followed by the study of patients with early (6–24h)
septic shock [14], which was designed to investigate this
apparent association between rectal lactate concentrations
and mortality. However, the observations could not be
reproduced in patients with septic shock for less than 24h
and the concentrations of lactate in the rectal lumen and
arterial lactate were both lower than in the previous study
[13]. One possible explanation for this discrepancy could4 Critical Care Research and Practice
Table 2: Daily parameters in 22 patients with septic shock stratiﬁed by survival.
Nonsurvivors Survivors
(n = 5) (n = 17)
Day 1 Day 2 Day 3 Day 1 Day 2 Day 3
Heart rate (bpm) 94 92 80 90 90 88
(88–114) (80–125) (70–95)a (82–96) (75–107) (81–104)
Sinus rhythm 5/5 4/5 3/3 14/17 12/17 10/12
Atrial ﬁbrillation 0/5 1/5 0/3 3/17 5/17 2/12
MAP (mmHg) 76 85 75 74 79 82
(67–80) (78–94) (73–108)a (70–79) (75–85) (71–92)
Noradrenaline dose 0.34 0.04 0.00 0.12 0.06 0.00
(μg/kg/min) (0.12–0.49) (0.01–0.09) (0.00–0.03)a (0.09–0.16) (0.00–0.22) (0.00–0.15)
ScvO2 ( % ) 7 97 87 37 47 67 6
(73–84) (75–80) (62–76)a (68–80) (70–80) (72–80)
IAP (mmHg) 14 16# 12 12 13 12
(11–16) (15–17) (11–14)a (11–15) (9–15) (8–17)
Lactate, arterial 1.9 1.5 1.4 1.8 2.0 1.4
(mmol/L) (1.6–8.2) (1.2–3.7) (1.4–3.4)a (1.4–3.4) (1.3–2.6) (1.1–2.2)
Lactate, rectal lumen 2.4 3.2 2.9 2.1 2.1 2.3
(mmol/ L) (1.3–7.5) (1.7–4.2) (1.5–3.0)a (1.2–4.4) (1.1–3.4) (0.9–3.0)
Delta-lactate −0.25 0.60 0.20 0.45 −0.10 0.30
(rectal-arterial (mmol/ L)) (−1.0–0.3) (−0.4–2.0) (−0.5–1.7) (−0.5–1.2) (−1.1–2.0) (−0.4–1.3)
Values are medians (25th–75th percentiles). #P = 0.02 compared with IAP day 2 in survivors. No other signiﬁcant diﬀerenceswere found using the Mann
Whitney test (comparing values between groups on speciﬁc days) or Wilcoxon’s signed rank test or Friedmans’s test (comparing paired values within groups
over 2 or 3 days, resp.). aRange since n = 3.
Table 3: SAPS II score, SOFA score at inclusion and day 5 of patients with an increase or decrease/no change In luminal rectal lactate from
day 1 to day 2 or from day 2 to day 3, respectively.
From day 1 to day 2 P From day 2 to day 3 P
Increase in Decrease in Increase in Decrease in
rectal lactate rectal lactate rectal lactate rectal lactate
(n = 11) (n = 11) (n = 7) (n = 8)
SAPS II 64 46 0.07 53 55 0.96
(48–74) (28–53) (46–74) (43–72)
S O F A 1 21 0 0 . 1 4 1 31 3 0 . 7 8
(at inclusion) (11–15) (8–13) (10–14) (10–16)
S O F A 8 80 . 6 78 70 . 5 4
(day 5) (4–13) (6–11) (8–13) (4–13)
Values are medians (25th–75th percentiles). Statistical analysis comparing values between patients with an increase or a decrease/no change in rectal luminal
lactate were done using the Mann-Whitney test.
be that in the ﬁrst study [13] most patients had their rectal
equilibrium dialysis when they had had septic shock for
48–72h. It could be speculated that there is a “delay” in
time in the development or change in the concentrations of
rectal lactate. Interestingly, Poeze et al. [18] did an excellent
study in 28 critically ill patients where they found that
regional variables (gastric mucosal pH and indocyanine
green clearance) were better to predict outcome than global
hemodynamic parameters, but only after initial stabilisation,
typically at least 12 hours.
However, the data of this present study cannot support
such a time-dependent change or development in the
concentrations of lactate in the rectal lumen in patients with
septic shock.
Were the patients in this present study less severely ill?
It seems unlikely since the SAPS II and SOFA scores were
high, but they did have arterial concentrations of lactate
in the lower range compared to other studies [13, 19–21].
However, such lower concentrations of arterial lactate have
been observed by others in both nonsurviving and survivingCritical Care Research and Practice 5
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Figure 1: Rectal luminal and arterial concentrations of lactate in nonsurvivors and survivors of septic shock. There was no signiﬁcant
diﬀerence between the groups on any day (Mann-Whitney test) or within the groups over the days (Wilcoxon’s signed rank test or Friedman
test comparing paired values within groups over 2 or 3 days, resp.). See also Table 2 and text.
patients with sepsis [18]. Also, we did not see the diﬀerence
in the arterial lactate concentrations between nonsurvivors
and survivors, which have been observed in other studies
[18–21], but our study was not speciﬁcally designed to
investigate arterial lactate concentrations. An important
diﬀerence could be that the values of arterial lactate reported
in our data is not strictly admission values or 24h values
but the corresponding arterial lactate concentrations at the
time of rectal equilibrium dialysis which was performed at
any time from 6–24h after onset of shock.
Because we did not observe any change in the rectal
concentrations of lactate in neither the group of nonsur-
vivors or survivors we analysed if there were any diﬀerence
in disease severity between the individual groups of patients
with increasing or decreasing/no change concentrations of
luminal lactate in the rectum. No such diﬀerence were found
regarding SAPS II score, SOFA score at inclusion or day
5, but the actual increases or decreases in rectal lactate
concentrations were small.
Perhaps most importantly, we did not observe any
diﬀerence in the concentrations of lactate in the rectal lumen
compared with the arterial concentrations, a ﬁnding which
also contrasts our earlier observations in septic patients
[12, 13, 16]. If the concentrations of lactate in the rectal
lumenarenodiﬀerentthanarterialconcentrationsoflactate,
no more information is gained by using this method trying
to assess metabolic dysfunction of the gut.
Are luminal concentrations of lactate a valid marker
of metabolic dysfunction? Animal studies indicates this
as concentrations of lactate in the intestinal lumen has
been studied in animal models of occlusive gut ischaemia
[22–25] and was found to be a more sensitive marker
of hypoperfusion-induced intestinal metabolic dysfunction
compared to lactate levels in blood or intestinal serosa or
mucosa.
There are many diﬀerent techniques available for assess-
ing blood ﬂow and the metabolic state of the gut [5–
8]. We believe our method of assessing luminal lactate in
the rectal lumen is valid based on our previous studies
in septic shock [12, 13, 16, 17], cardiac surgery [26], and
the earlier studies by others on inﬂammatory bowel disease
[9–11]. Thus, Perner and coworkers [26]f o u n da2 -t o6 Critical Care Research and Practice
Lactate nonsurvivors day 1
Rectal Arterial
0
2.5
5
7.5
10
12.5
P = 0.44
(
m
m
o
l
/
L
)
(a)
Lactate survivors day 1
Rectal Arterial
0
2.5
5
7.5
10
12.5
P = 0.21
(
m
m
o
l
/
L
)
(b)
Lactate nonsurvivors day 2
Rectal Arterial
0
2.5
5
7.5
10
12.5
P = 0.38
(
m
m
o
l
/
L
)
(c)
Lactate survivors day 2
Rectal Arterial
0
2.5
5
7.5
10
12.5
P = 0.55
(
m
m
o
l
/
L
)
(d)
Lactate nonsurvivors day 3
Rectal Arterial
0
2.5
5
7.5
10
12.5
P = 0.75
(
m
m
o
l
/
L
)
(e)
Lactate survivors day 3
Rectal Arterial
0
2.5
5
7.5
10
12.5
P = 0.18
(
m
m
o
l
/
L
)
(f)
Figure 2: Rectal and arterial concentrations of lactate in nonsurvivors and survivors of septic shock. There were no diﬀerences using
Wilcoxon’s signed rank test.
3-fold increase in concentrations of lactate in the rectal
lumen in patients during coronary artery bypass grafting
(CABG) with cardiopulmonary bypass as compared to oﬀ-
pump CABG and healthy subjects. Similar results have been
obtained by others. Using a microdialysis catheter Sollig˚ ard
and coworkers found a 10-fold increase in luminal rectal
lactate in patients during cardiopulmonary bypass [27]. In
our opinion these observations support the notion that
luminal concentrations of lactate in the rectum could be a
marker of ischaemia or metabolic dysfunction.
So, could our results reﬂect that the patients in both
our study in early septic shock [14] and the present study
did not have hypoperfusion or metabolic dysfunction of the
gut and that the patients in our earlier studies did have
detectable metabolic dysfunction or hypoperfusion? Unfor-
tunately neither of the studies were designed to evaluate thisCritical Care Research and Practice 7
issue further, since we opted for a more simple study design
in order to better facilitate enrolment of patients. But this
should be an important question to address in future studies.
5. Conclusion
Our study showed no change or development in the con-
centrations of lactate in the rectal lumen over the ﬁrst 3
days in patients with septic shock or any diﬀerence between
nonsurvivors and survivors. We found no diﬀerence between
luminal rectal and arterial concentrations of lactate at any
point. At present, the role of rectal equilibrium dialysis
outside experimental trials is not deﬁned and needs further
investigation,ideallyinstudiesalsoevaluatingothermethods
of assessing gut metabolic function or blood ﬂow.
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